11 November 2021
GENEVA – The Global Fund to Fight AIDS, Tuberculosis and Malaria enthusiastically welcomes President Joe Biden's decision to host the Global Fund’s Seventh Replenishment Conference in the United States in the second half of 2022.
The Conference, held every three years, convenes leaders from governments, civil society, the private sector and communities affected by the three most devastating infectious diseases.
“Once again, the United States is demonstrating tremendous leadership in global health,” said Peter Sands, Executive Director of the Global Fund. “As the largest donor to the Global Fund and as a longstanding champion of the fight against HIV, TB and malaria, through both its support to the Global Fund and its bilateral programs, the United States is superbly placed to host our next Replenishment.”
The Global Fund raises money on a three-year cycle. At the Sixth Replenishment, hosted by President Emmanuel Macron in Lyon, France, in October 2019, the Global Fund received an unprecedented amount of US$14 billion in pledges to fund grants over the three years 2021 to 2023.
The Seventh Replenishment, which will take place in a challenging global health landscape, will seek to secure pledges to fund grants for the three years 2024 to 2026, which correspond to the first half of the next Global Fund Strategy that has just been approved by the Board.
The United States is the largest donor to the Global Fund, having provided, thanks to unwavering bipartisan support, a cumulative total of US$17 billion since the establishment of the partnership 20 years ago. In the current cycle, the United States is expected to provide US$1.56 billion per year. In addition, in 2021, the United States has provided an additional US$3.5 billion to the Global Fund’s COVID-19 Response Mechanism (C19RM) to help low- and middle-income countries respond to the pandemic, mitigate its impact on HIV, TB and malaria services, and make urgent improvements to health systems. This extremely generous contribution, combined with contributions from other donors, has enabled the Global Fund to be the largest provider of grant support to low- and middle-income countries for all the non-vaccine components of the COVID-19 response.
The Global Fund partners closely with PEPFAR, USAID and PMI in supporting countries in combatting HIV, TB and malaria and building resilient and sustainable systems for health.
“We are immensely grateful to President Biden and the U.S. for their leadership in global health and their strong partnership with countries to make progress against the deadliest infectious diseases, including the current devastating COVID-19 pandemic,” said Dr. Donald Kaberuka, Global Fund Board Chair. “The entire Global Fund partnership – implementing countries, donors, civil society and communities, the private sector, technical partners, advocates and champions – all look forward to joining forces to make this Replenishment a success to continue to save lives and get back on track in the fight against HIV, TB and malaria.”
The newly approved Strategy represents a significant step forward from the current Strategy and will help lift the performance and impact of the Global Fund partnership to better address the dramatic changes resulting from COVID-19 and expedite the fight to get back on track toward the 2030 goal of ending HIV, TB and malaria. The grants based upon the new Strategy will start in January 2024 with funds from the upcoming Seventh Replenishment.